Ideaya Biosciences Stock Analysis

Ideaya Stock Analysis Notes

About 99.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.96. Some equities with similar Price to Book (P/B) outperform the market in the long run. Ideaya Biosciences recorded a loss per share of 2.33. The entity had not issued any dividends in recent years. IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. IDEAYA Biosciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California. Ideaya Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 91 people. To learn more about Ideaya Biosciences call the company at 650 443 6209 or check out https://www.ideayabio.com.

Ideaya Biosciences Investment Alerts

Ideaya Biosciences Upcoming and Recent Events

Ideaya Largest EPS Surprises

View All Earnings Estimates

Ideaya Biosciences Environmental, Social, and Governance (ESG) Scores

Ideaya Stock Institutional Investors

Note, although Ideaya Biosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Ideaya Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.32 B.

Ideaya Profitablity

Management Efficiency

Ideaya Biosciences has return on total asset (ROA) of (0.1585) % which means that it has lost $0.1585 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.211) %, meaning that it created substantial loss on money invested by shareholders. Ideaya Biosciences' management efficiency ratios could be used to measure how well Ideaya Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. As of November 26, 2024, Return On Tangible Assets is expected to decline to -0.18. In addition to that, Return On Capital Employed is expected to decline to -0.23. At present, Ideaya Biosciences' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 422 M, whereas Non Currrent Assets Other are forecasted to decline to about 416.2 K.

Technical Drivers

As of the 26th of November, Ideaya Biosciences retains the Standard Deviation of 2.91, market risk adjusted performance of (0.30), and Risk Adjusted Performance of (0.12). Ideaya Biosciences technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Ideaya Biosciences Price Movement Analysis

Ideaya Biosciences Insider Trading Activities

Ideaya Biosciences Outstanding Bonds

Ideaya Biosciences Predictive Daily Indicators

Ideaya Biosciences Corporate Filings

Ideaya Biosciences Forecast Models

Ideaya Biosciences' time-series forecasting models are one of many Ideaya Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Ideaya Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Ideaya Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Ideaya shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Ideaya Biosciences. By using and applying Ideaya Stock analysis, traders can create a robust methodology for identifying Ideaya entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Ideaya analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Ideaya analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Ideaya Biosciences stock analysis indicators help investors evaluate how Ideaya Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Ideaya Biosciences shares will generate the highest return on investment. By understating and applying Ideaya Biosciences stock analysis, traders can identify Ideaya Biosciences position entry and exit signals to maximize returns.

When running Ideaya Biosciences' price analysis, check to measure Ideaya Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ideaya Biosciences is operating at the current time. Most of Ideaya Biosciences' value examination focuses on studying past and present price action to predict the probability of Ideaya Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ideaya Biosciences' price. Additionally, you may evaluate how the addition of Ideaya Biosciences to your portfolios can decrease your overall portfolio volatility.